22+ hour, 45+ min ago  (168+ words) 09 April 2026 | Thursday | News Lumonus, the company behind Lumonus AI, a platform for radiation oncology clinical workflow and automated treatment planning, announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK), one of the world's premier cancer centers and a leader…...

22+ hour, 45+ min ago  (190+ words) 09 April 2026 | Thursday | News Tri Net X" will continue to support all existing Zetta Genomics customers utilizing the award-winning Xeta Base" technology for research and patient care innovation Zetta's flagship platform, Xeta Base, is a multiomic capture and analytics platform designed…...

22+ hour, 45+ min ago  (84+ words) 09 April 2026 | Thursday | News ASC30 is a Phase III-ready oral small molecule GLP-1 R agonist that had a favorable gastrointestinal (GI) profile with half the rate of vomiting vs. orforglipron, when both drugs are dosed with weekly titration in non-head-to-head studies (Press…...

22+ hour, 45+ min ago  (194+ words) 09 April 2026 | Thursday | News Singlomics Biopharmaceuticals, an innovative clinical-stage biopharmaceutical company focused on the discovery and development of antibody therapeutics for oncology, inflammation, and autoimmune diseases, today announced that the first patient has been dosed in its Phase I clinical trial…...

1+ day, 13+ hour ago  (190+ words) 07 April 2026 | Tuesday | News The study, titled "Development and Validation of an Enzyme-Linked Immunosorbent Assay for Measuring Factor XI in Intravenous Immunoglobulin Products by Mitigating Heterophilic Antibody Interference," was published in the April 2026 issue of the Journal of Microbiology and Biotechnology…...

2+ day, 3+ hour ago  (996+ words) 07 April 2026 | Tuesday | News At the same time, many individuals who may benefit from semaglutide are also taking anticoagulant or antiplatelet medications, commonly referred to as blood thinners. These drugs are prescribed to reduce the risk of blood clots, stroke, or…...

1+ day, 22+ hour ago  (168+ words) 08 April 2026 | Wednesday | News "Achieving carbon neutrality in our owned manufacturing operations marks a significant milestone in Boehringer Ingelheim's decarbonization strategy," said Andy Brehm, Executive Director, U. S. Site Operations " Athens at Boehringer Ingelheim. "This achievement reflects our ongoing efforts to reduce our…...

1+ day, 22+ hour ago  (182+ words) 08 April 2026 | Wednesday | News Primary and Key Secondary Endpoints Met Study Showed Clinically Meaningful Reduction in Proptosis; Greater Than 3 mm The Phase 3 TEPEZZA OBI trial met its primary endpoint in moderate-to-severe active TED, showing a statistically significant and clinically meaningful 77% proptosis…...

1+ day, 22+ hour ago  (101+ words) 08 April 2026 | Wednesday | News The SBM based on the new algorithm is therefore much faster. It delivers a time to solution (TTS) required to obtain an optimal or known best solution that is approximately 100 times faster than the SBM based on…...

2+ day, 9+ hour ago  (627+ words) 07 April 2026 | Tuesday | News This evaluation pulled from vendor documentation, G2 and Capterra user reviews, and verified product and certification details in early 2026. Each platform was measured against five benchmarks that matter most to healthcare compliance teams selecting a GRC system. Here…...